Research of Predictive Factors of in Vitro Fertilization (IVF) Outcome AI-IVF Study
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
- Study ID
- NCT06872294
- Status
- Recruiting
Conditions
- Autoimmune Diseases
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 43 Years
- Healthy Volunteers
- Not accepted
Study Details
Infertility is the failure to achieve a clinical pregnancy after 12 months or more of regular unprotected intercourse, while subfertility means a delay in achieving pregnancy. Several factors can contribute to these conditions, such as autoimmune diseases like systemic thyroid and celiac diseases, rheumatoid arthritis, systemic lupus erythematosus, and endometriosis. Some of them may overlap, sharing a common immunological milieu. In this scenario, medically ART can help women carry on pregnancies if they are in stable disease remission and receive adequate treatment. However, the number of oocytes that can be ovulated under stimulation is highly variable, so the outcome of any IVF is linked to many factors, not only biological but also connected to the mean success rate of the fertility center. For these reasons, the need to find methods for identifying the best gametes and embryos to guarantee a successful pregnancy is becoming pressing. AI can be essential to develop prediction models for pregnancy outcomes for patients undergoing ART treatments. AI currently represents a modern way to obtain algorithms from a set of observable data that could help clinical decisions
Key Dates
- First listed
- Mar 12, 2025
- Start date
- Nov 22, 2024
- Status verified
- Mar 2025
- Primary completion
- Dec 31, 2025
- Completion
- Dec 31, 2025
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: patients with a positive autoimmune panelWomen undergoing ART procedures with a positive autoimmune panel
- Arm: patients with a negative autoimmune panelWomen undergoing ART procedures with a negative autoimmune panel
Primary Outcome Measure
Predictive algorithm creation [ Time Frame: through study completion, an average of 2 years ]
Central Contacts
- Claudia Omes, PhD+390382503238
Related Studies
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)Recruiting · Center for International Blood and Marrow Transplant Research · Birmingham, Alabama
- Comparative Autoantibody and Immunologic Cell Marker StudyEnrolling By Invitation · Emory University · Atlanta, Georgia
- Maternal Autoimmune Disease Research Alliance (MADRA) RegistryRecruiting · Duke University · Durham, North Carolina
- Collection and Distribution of Biospecimens for Novel Research UsesRecruiting · iSpecimen Inc · Huntsville, Alabama